Every substance that is considered for clinical studies is refined, optimized and comprehensively tested to provide sufficient evidence of its safety and effectiveness before clinical tests on people can begin.

Before clinical trials can begin, teams must scale-up production to ensure an adequate supply of the investigation candidate for clinical trials. This means scaling up production from small batches made in the labs to larger scale quantities formulated for clinical use in people.